GO:2000173 negative regulation of branching morphogenesis of a nerve: Signaling Brakes, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000173 describes any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
• It is a biological_process term that acts as a negative regulatory brake on axon and dendrite branching, a process essential for correct neural circuit wiring.
• Semaphorins, plexins, sprouty proteins and neurotrophic factor signaling pathways are central molecular players in this negative regulation.
• Dysregulation of nerve branching underlies neurodevelopmental disorders, peripheral neuropathies and cancer perineural invasion.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of candidate negative regulators in neurons and organoids.
• The term is distinct from positive regulation of branching morphogenesis and from branching morphogenesis itself, and must be studied with that specificity.
Description
GO:2000173, negative regulation of branching morphogenesis of a nerve, is a Gene Ontology biological_process term that captures the active suppression of nerve branching. Branching morphogenesis of a nerve is the developmental process by which axons and dendrites extend secondary and higher-order branches to innervate targets and form complex arbors. Because unchecked branching can lead to aberrant wiring, hyperinnervation or tumor innervation, cells deploy dedicated negative regulators that stop, prevent or reduce the frequency, rate or extent of this branching. Understanding GO:2000173 is therefore essential for researchers studying neural development, regeneration and disease.
negative regulation of branching morphogenesis of a nerve At A Glance
| GO ID | GO:2000173 |
|---|---|
| GO term | negative regulation of branching morphogenesis of a nerve |
| Ontology | biological_process |
| Synonym | none |
| Major function | Suppression of axon/dendrite branching frequency, rate or extent |
| Parent terms | negative regulation of developmental process; regulation of branching morphogenesis of a nerve |
| Related processes | axon guidance, dendrite morphogenesis, neurotrophic signaling |
| Key molecular players | Semaphorins, Plexins, Sprouty proteins, BDNF/TrkB signaling |
| Disease relevance | Neurodevelopmental disorders, peripheral neuropathy, cancer perineural invasion |
What Is GO:2000173?
In plain terms, GO:2000173 refers to any biological process that puts the brakes on nerve branching. According to the QuickGO definition, it is any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve. This is a regulatory term: it does not describe the branching machinery itself, but the signals and mechanisms that restrain it. It is a child of negative regulation of developmental process and is specific to nerves, distinguishing it from negative regulation of branching in other organs such as lung or kidney.
Why Is negative regulation of branching morphogenesis of a nerve Important in Cell Biology?
GO:2000173 matters because nerve branching is a double-edged sword: it is required for proper circuit formation, but excessive or misdirected branching contributes to neurodevelopmental disorders, chronic pain, and perineural invasion in cancer. Negative regulators encoded by genes such as semaphorins and sprouty proteins provide the spatial and temporal control that keeps branching within physiological limits. Loss of these brakes can cause hyperinnervation, while excessive brake activity can impair regeneration. Thus, this GO term provides a framework for interpreting genetic and pharmacological perturbations in neural development and disease.
• Defines the molecular brakes that prevent excessive axon and dendrite branching during development.
• Provides a mechanistic explanation for how guidance cues such as semaphorins restrict branching to appropriate targets.
• Links neurotrophic factor signaling, including BDNF/TrkB, to spatial restriction of axonal arbors.
• Explains how loss of negative regulators can cause hyperinnervation and neuropathic pain.
• Relevant to cancer biology, where nerves promote tumor growth and perineural invasion.
• Guides regenerative medicine strategies by identifying brakes that may need to be released after injury.
• Supports interpretation of single-cell and spatial transcriptomics of developing neural tissues.
• Offers a testable framework for CRISPR screens aimed at discovering new branching regulators.
• Helps distinguish nerve-specific branching control from branching in lung or kidney.
• Informs drug target selection for disorders of neural wiring and plasticity.
What Happens During negative regulation of branching morphogenesis of a nerve?
Initiation of negative signals at the growth cone
In simple terms: The tip of the growing nerve receives stop signals that tell it not to branch.
Negative regulation begins when repulsive guidance cues such as semaphorins bind to receptors on the growth cone. Semaphorins are expressed in developing lung and neural tissues and can act as positive or negative regulators of branching, with specific family members restricting branching. In the nervous system, these cues activate intracellular signaling that locally collapses the growth cone cytoskeleton, preventing new branch initiation.
Receptor complex assembly and signal transduction
In simple terms: Stop signals are received by receptor complexes that relay the message inside the cell.
Semaphorins signal through plexin receptors, often with neuropilin co-receptors. Plexin D1 is a key receptor that negatively regulates developmental processes, as shown in zebrafish where it restricts lymphatic development. In nerves, plexin-mediated signaling recruits GTPase-activating proteins and kinases that remodel actin and microtubules, thereby reducing the frequency of branch formation.
Modulation by neurotrophic factor pathways
In simple terms: Growth factor signals can be dampened by intracellular brakes to limit branching.
Neurotrophic factors such as BDNF promote branching, but their signaling is tempered by negative regulators. Sprouty3 is a new regulator of BDNF signalling involved in axonal morphogenesis in vivo, and its expression restricts excessive branching. Neurotrophic factors also act in non-neuronal tissues, indicating that similar negative control mechanisms may be shared.
Cytoskeletal and transcriptional effectors
In simple terms: The stop signal ultimately changes the skeleton of the nerve cell and gene expression.
Downstream of receptor activation, Rho-family GTPases and actin-binding proteins promote growth cone collapse and retraction, reducing branch number. Transcriptional programs may also be engaged, as suggested by interactome studies of the KICSTOR complex, which links nutrient sensing to developmental signaling. These effectors ensure that negative regulation is durable and spatially restricted.
Integration with tissue-level morphogenesis
In simple terms: The brakes on nerve branching must coordinate with surrounding tissues.
Nerve branching does not occur in isolation; it is influenced by neighboring cells and extracellular matrix. In the thymus, medullary specialization involves interactions between developing nerves and epithelial cells, and similar crosstalk may restrict branching. In bone, Schwann cell-derived extracellular vesicles inhibit osteoclastogenesis through the PTEN/AKT axis, illustrating how nerve-associated cells can signal to other tissues and potentially influence branching indirectly.
Key Genes Involved in GO:2000173 negative regulation of branching morphogenesis of a nerve
The following genes and proteins have been experimentally linked to negative regulation of nerve branching or closely related morphogenetic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEMA3A | Secreted semaphorin that repels growth cones and restricts branching | Studied in lung and neural branching morphogenesis |
| PLXND1 | Plexin D1 receptor for semaphorins; negative regulator of development | Zebrafish lymphatic and neural development |
| SPRY3 | Sprouty3, negative regulator of BDNF signalling | Axonal morphogenesis in vivo |
| BDNF | Neurotrophic factor promoting branching; its signaling is tempered by Sprouty3 | Neuronal development and plasticity |
| NTRK2 | TrkB receptor for BDNF | Mediates neurotrophic signaling in neurons |
| PTEN | Phosphatase that negatively regulates AKT signaling | Schwann cell-derived EV effects on osteoclastogenesis |
| AKT1 | Kinase in PI3K/AKT pathway | Downstream of PTEN in nerve-bone crosstalk |
| SZT2 | Component of KICSTOR complex | Interactome links to developmental signaling |
| KPTN | KICSTOR complex subunit | mTOR regulation and neural development |
| NPRL2 | KICSTOR complex subunit | Nutrient sensing and morphogenesis |
| NPRL3 | KICSTOR complex subunit | mTORC1 regulation |
| DEPDC5 | KICSTOR complex subunit | Developmental and epilepsy-related signaling |
| SEMA4D | Semaphorin family member | Potential negative regulator of branching |
| SEMA5A | Semaphorin family member | Potential negative regulator of branching |
| NRP1 | Neuropilin co-receptor for semaphorins | Modulates repulsive signaling |
| NRP2 | Neuropilin co-receptor | Modulates repulsive signaling |
| RHOA | Rho GTPase mediating growth cone collapse | Cytoskeletal effector of negative regulation |
How Is negative regulation of branching morphogenesis of a nerve Regulated?
Negative regulation of nerve branching is itself regulated at multiple levels. Semaphorin expression is dynamically controlled by transcription factors and extracellular cues during development. Neurotrophic factor signaling through BDNF/TrkB is modulated by Sprouty3, which acts as an intracellular brake. The KICSTOR complex, through its interaction with SZT2 and other subunits, regulates mTORC1 signaling, which in turn influences cell growth and morphogenesis. Additionally, Schwann cell-derived extracellular vesicles can modulate signaling in neighboring cells via the PTEN/AKT axis, suggesting a non-cell-autonomous layer of regulation.
negative regulation of branching morphogenesis of a nerve and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SEMA3A | Neurodevelopmental disorders, cancer | Knockout mouse, neuronal culture |
| PLXND1 | Lymphatic and neural development | Zebrafish knockout |
| SPRY3 | Axonal morphogenesis, neuropsychiatric disorders | Mouse knockout, primary neurons |
| PTEN | Peripheral neuropathy, bone remodeling | Schwann cell-specific knockout |
| SZT2 | mTOR-related developmental disorders | Patient-derived iPSC neurons |
Neurodevelopmental disorders
Disruption of negative regulators of nerve branching can lead to abnormal wiring and neurodevelopmental phenotypes. For example, mutations affecting semaphorin signaling are associated with altered neural connectivity. The KICSTOR complex, which includes SZT2, is linked to mTOR-related developmental disorders, and its interactome suggests roles in neural morphogenesis.
Peripheral neuropathy and pain
Loss of negative regulation can cause hyperinnervation, contributing to neuropathic pain. Schwann cell-derived extracellular vesicles modulate the PTEN/AKT axis in peripheral nerve-bone crosstalk, indicating that nerve-derived signals can influence bone remodeling and potentially pain states. Sprouty3, by restricting BDNF signaling, may protect against excessive axonal branching.
Cancer perineural invasion
Nerves can promote tumor growth and perineural invasion. Plexin D1 negatively regulates developmental processes and is implicated in lymphatic development, a process co-opted in cancer. Semaphorins, which can inhibit branching, may act as tumor suppressors in certain contexts.
From negative regulation of branching morphogenesis of a nerve-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SEMA3A increase nerve branching? | SEMA3A knockout mouse or CRISPR KO in neurons |
| Does a point mutation in PLXND1 alter receptor function? | CRISPR point-mutation knock-in in zebrafish |
| Can we tag SPRY3 to track its localization? | Tagged knock-in of SPRY3 in mouse |
| Does overexpression of PTEN reduce branching? | Lentiviral overexpression in Schwann cells |
| Which genes regulate branching in a genome-wide manner? | CRISPR library screening in neuronal cells |
| Does SZT2 mutation affect mTOR signaling and branching? | Patient iPSC-derived neurons with SZT2 KO |
How to Study the negative regulation of branching morphogenesis of a nerve Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify regulators of branching |
| Single-cell RNA-seq | Cell-type-specific expression | Resolve neuronal heterogeneity |
| Affinity proteomics | Protein-protein interactions | Define KICSTOR complex |
| Live imaging | Branch dynamics | Track axon branching in vivo |
| CRISPR knockout | Loss-of-function effects | Test candidate negative regulators |
| CRISPR point mutation | Specific amino acid function | Dissect receptor signaling |
| Overexpression | Gain-of-function effects | Assess PTEN/AKT axis |
| In situ hybridization | Spatial expression patterns | Map semaphorin expression |
Transcriptomics and single-cell RNA-seq
RNA-seq and single-cell RNA-seq can identify genes whose expression correlates with negative regulation of branching. For example, semaphorin expression patterns in developing lung were characterized by in situ hybridization and transcriptomics. Single-cell approaches can resolve heterogeneity in branching neurons and their regulators.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry has been used to define the SZT2 interactome, revealing new functions of the KICSTOR complex. Similar approaches can identify protein complexes that mediate negative regulation of nerve branching, such as plexin-associated proteins.
Live imaging of branching morphogenesis
Time-lapse imaging of fluorescently labeled neurons allows direct measurement of branch initiation, extension and retraction. This has been applied to study Sprouty3 in axonal morphogenesis in vivo. Zebrafish and mouse models enable visualization of nerve branching in intact tissues.
Functional perturbation with CRISPR
CRISPR knockout, point mutation, knock-in and overexpression enable causal testing of candidate genes. For example, knockout of plexin D1 in zebrafish demonstrated its negative regulatory role. Overexpression of PTEN in Schwann cells altered osteoclastogenesis, illustrating functional consequences.
How CRISPR Can Be Used to Study GO:2000173 negative regulation of branching morphogenesis of a nerve
Knockout
CRISPR knockout is used to delete candidate negative regulators such as SEMA3A or PLXND1 and assess whether nerve branching increases. For example, plexin D1 knockout in zebrafish revealed its negative regulatory role in development. Knockout of SZT2 can be used to study KICSTOR complex function.
Point Mutation
Point mutations can be introduced to dissect specific domains or phosphorylation sites in receptors like plexin D1 or kinases like AKT1. This allows precise testing of signaling mechanisms without confounding effects of full gene deletion.
Knock-in
Knock-in of tags or reporters (e.g., GFP, HA) into endogenous loci such as SPRY3 enables real-time tracking of protein localization and dynamics during branching. Knock-in of disease-associated mutations can model human neurodevelopmental disorders.
Overexpression
Overexpression of negative regulators such as PTEN or Sprouty3 can suppress branching and test sufficiency. For instance, overexpression of PTEN in Schwann cells altered osteoclastogenesis via the AKT axis. Overexpression of semaphorins can inhibit branching in lung and neural tissues.
How EDITGENE Supports negative regulation of branching morphogenesis of a nerve Research
Researchers studying negative regulation of branching morphogenesis of a nerve-related genes often need to determine whether a candidate gene is causally involved in restricting nerve branching or is merely correlated. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes implicated in GO:2000173.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of branching morphogenesis of a nerve research.
Frequently Asked Questions About negative regulation of branching morphogenesis of a nerve
What is GO:2000173?
GO:2000173 is the Gene Ontology term for negative regulation of branching morphogenesis of a nerve, defined as any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
What genes are involved in negative regulation of branching morphogenesis of a nerve?
Key genes include SEMA3A, PLXND1, SPRY3, BDNF, NTRK2, PTEN, AKT1 and components of the KICSTOR complex such as SZT2.
How is nerve branching negatively regulated?
Negative regulation occurs through repulsive guidance cues like semaphorins, receptor complexes such as plexin D1, intracellular brakes like Sprouty3, and modulation of neurotrophic factor signaling.
What is the difference between GO:2000173 and branching morphogenesis of a nerve?
Branching morphogenesis of a nerve is the process of forming branches, while GO:2000173 specifically describes the processes that inhibit or reduce that branching.
Why is negative regulation of nerve branching important in disease?
Loss of negative regulation can cause hyperinnervation, neuropathic pain and contribute to cancer perineural invasion, while excessive regulation may impair regeneration.
What model systems are used to study GO:2000173?
Common models include zebrafish, mice, primary neuronal cultures, and patient-derived iPSCs, often combined with CRISPR knockout or overexpression.
Can CRISPR be used to study negative regulation of nerve branching?
Yes, CRISPR knockout, point mutation, knock-in and overexpression are powerful tools to test the causal role of candidate genes in this process.
What is the role of semaphorins in nerve branching?
Semaphorins can act as positive or negative regulators of branching; specific semaphorins restrict branching in lung and neural tissues.
How does Sprouty3 regulate nerve branching?
Sprouty3 is a negative regulator of BDNF signalling and is involved in axonal morphogenesis in vivo, thereby limiting excessive branching.
What services does EDITGENE offer for GO:2000173 research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening and bioinformatics services to study genes involved in negative regulation of nerve branching.
Conclusion
GO:2000173, negative regulation of branching morphogenesis of a nerve, is a critical biological process that ensures proper neural wiring by restraining excessive branching. Its molecular players, including semaphorins, plexins, Sprouty3 and KICSTOR components, are increasingly linked to neurodevelopmental disorders, pain and cancer. Understanding this process requires precise functional perturbation, and CRISPR-based models are indispensable for causal validation. EDITGENE provides the tools and expertise to accelerate discoveries in this field.
References
- 1. Sakurai H. 2003. Molecular mechanism of ureteric bud development.. Semin Cell Dev Biol 14(4):217-24 PMID: 14627120
- 2. Britto DD et al.. 2022. Plexin D1 negatively regulates zebrafish lymphatic development.. Development 149(21) PMID: 36205097
- 3. Yang H et al.. 2026. Schwann cell-derived extracellular vesicles inhibit osteoclastogenesis through the PTEN/AKT axis in peripheral nerve-bone crosstalk.. J Nanobiotechnology 24(1):144 PMID: 41530784
- 4. Kagoshima M et al.. 2001. Diverse gene expression and function of semaphorins in developing lung: positive and negative regulatory roles of semaphorins in lung branching morphogenesis.. Genes Cells 6(6):559-71 PMID: 11442635
- 5. Cattelani C et al.. 2021. The SZT2 Interactome Unravels New Functions of the KICSTOR Complex.. Cells 10(10) PMID: 34685691
- 6. Panagiotaki N et al.. 2010. Characterisation of a new regulator of BDNF signalling, Sprouty3, involved in axonal morphogenesis in vivo.. Development 137(23):4005-15 PMID: 21062861
- 7. Sariola H. 2001. The neurotrophic factors in non-neuronal tissues.. Cell Mol Life Sci 58(8):1061-6 PMID: 11529499
- 8. Cosway EJ et al.. 2017. Redefining thymus medulla specialization for central tolerance.. J Exp Med 214(11):3183-3195 PMID: 28830910
